Literature DB >> 23732965

Psychiatric clearance for patients started on interferon-alpha-based therapies.

Francis E Lotrich1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732965      PMCID: PMC4044705          DOI: 10.1176/appi.ajp.2013.12121572

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  64 in total

1.  Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.

Authors:  Rosalind G Hoffman; Mary Ann Cohen; César A Alfonso; Jeffrey J Weiss; Sian Jones; Marla Keller; Juan R Condemarín; Nien-Mu Chiu; Jeffrey M Jacobson
Journal:  Psychosomatics       Date:  2003 Sep-Oct       Impact factor: 2.386

2.  Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.

Authors:  Chiadi U Onyike; John O Bonner; Constantine G Lyketsos; Glenn J Treisman
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

3.  Depression during treatment with interferon alpha.

Authors:  Martin Schaefer; Folkhard Schmidt; Martin Horn; Monika-Hildegard Schmid-Wendtner; Matthias Volkenandt
Journal:  Psychosomatics       Date:  2004 Mar-Apr       Impact factor: 2.386

4.  Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.

Authors:  Jennifer C Felger; Oyetunde Alagbe; Thaddeus W W Pace; Bobbi J Woolwine; Fang Hu; Charles L Raison; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2011-02-26       Impact factor: 7.217

5.  Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.

Authors:  Francis E Lotrich; Robert E Ferrell; Mordechai Rabinovitz; Bruce G Pollock
Journal:  Clin Neuropharmacol       Date:  2010-07       Impact factor: 1.592

6.  Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

Authors:  Lucile Capuron; Charles L Raison; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Andrew H Miller
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

7.  Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

Authors:  Lucile Capuron; Gabriele Neurauter; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Dietmar Fuchs; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2003-11-01       Impact factor: 13.382

8.  Repeated injections of interferon-alpha A/D in Balb/c mice: behavioral effects.

Authors:  A L Dunn; L S Crnic
Journal:  Brain Behav Immun       Date:  1993-03       Impact factor: 7.217

9.  The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.

Authors:  Marieke C Wichers; Michael Maes
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

10.  Plasma levels of citalopram in depressed patients with hepatitis C.

Authors:  Ondria C Gleason; William R Yates; Michelle A Philipsen; M Daniel Isbell; Bruce G Pollock
Journal:  Psychosomatics       Date:  2004 Jan-Feb       Impact factor: 2.386

View more
  1 in total

1.  Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites.

Authors:  Darin J Knapp; Kathryn M Harper; Buddy A Whitman; Zachary Zimomra; George R Breese
Journal:  Brain Sci       Date:  2016-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.